Cardiawave reports first Valvosoft treatments in Europe

Innovation
Cardiawave has announced the first patients treated in Europe with its Valvosoft platform, following the system’s CE mark approval for severe symptomatic aortic stenosis (sSAS). Valvosoft uses non-invasive focused ultrasound therapy to restore movement in...

Cardiawave reports first Valvosoft treatments in Europe

Innovation
Cardiawave has announced the first patients treated in Europe with its Valvosoft platform, following the system’s CE mark approval for severe symptomatic aortic stenosis...

Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

Regulatory Approvals
Distalmotion has received FDA 510(k) clearance to expand the use of its Dexter surgical robot across additional gynecologic procedures, including sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and...

SurGenTec gets FDA nod for lumbar facet fixation system

Regulatory Approvals
SurGenTec has received FDA clearance for its ION-L lumbar facet fixation system for patients with degenerative disc disease (DDD) affecting the L3 to S1...

UNEEG Medical announces FDA 510(k) clearance for UNEEG EpiSight System

Regulatory Approvals
UNEEG Medical has received FDA 510(k) clearance for its UNEEG EpiSight System, a minimally invasive implant designed for continuous, long-term EEG monitoring in patients...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Innovation

Regulatory Approvals

Cardiawave reports first Valvosoft treatments in Europe

Cardiawave has announced the first patients treated in Europe with its Valvosoft platform, following the system’s CE mark approval for severe symptomatic aortic stenosis...

Distalmotion gets FDA nod to expand Dexter surgical robot indications to gynecology

Distalmotion has received FDA 510(k) clearance to expand the use of its Dexter surgical robot across additional gynecologic procedures, including sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and...

SurGenTec gets FDA nod for lumbar facet fixation system

SurGenTec has received FDA clearance for its ION-L lumbar facet fixation system for patients with degenerative disc disease (DDD) affecting the L3 to S1...

UNEEG Medical announces FDA 510(k) clearance for UNEEG EpiSight System

UNEEG Medical has received FDA 510(k) clearance for its UNEEG EpiSight System, a minimally invasive implant designed for continuous, long-term EEG monitoring in patients...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1155Regulatory Approvals1026Innovation656Clinical Trials527Mergers & Acquisitions511GS Funding Tracker53